Back to search

Poland· PL-100420360

Calcium-Sandoz Forte

A a12aa04, a12aa06 product containing calcii glubionas + calcii carbonas, registered in Poland by Pharmapoint SA.

ATC A12AA04, A12AA06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCalcium-Sandoz ForteATCA12AA04, A12AA06REGISTER NO.PL-100420360PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Calcii glubionas + Calcii carbonas
Manufacturer
Pharmapoint SA
Country
Poland (PL)
ATC code
A12AA04, A12AA06
ATC class
A12AA04, A12AA06
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991403324

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f687a589-ca2d-44e3-9602-d7b30c979c7d
GET /v1/drugs/f687a589-ca2d-44e3-9602-d7b30c979c7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki musujące",
  "source": "urpl",
  "strength": "500 mg Ca2+",
  "packaging": "05909991403324 ¦ OTC ¦ 132633\n20 tabl.",
  "substance": "Calcii glubionas 1132 mg + Calcii carbonas 875 mg",
  "common_name": "Calcii glubionas + Calcii carbonas",
  "pl_product_id": "100420360",
  "pozwolenie_nr": "208/19",
  "auth_procedure": "IR",
  "authorisation_validity": "2024-05-30"
}

See everything about calcii glubionas + calcii carbonas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.